Home | Structured Search | Drug Resource
Find: within
Hypothermia > Prevention Author: Dmitri Guvakov, MD, PhD; Stuart Weiss, MD, PhD; Albert Cheung, MD
Module updated - 2009-05-21
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Alcohol and other drugs, such as meperidine and phenothiazines, interfere with the body's capacity to generate heat by shivering.
  • Decreases in the level of physical exercise (related to drug-induced sedation or physical immobility) will decrease heat production.
  • Compromised mental faculties related to drugs, alcohol ingestion, senile dementia, or cerebral vascular accident can cloud judgment and increase the patient's risk of prolonged exposure.
  • Malnutrition characterized by decreased body fat may compromise thermal homeostasis by significantly reducing the body's energy supply and thermal insulation.
  • Elderly persons often have a lower core temperature, which is related to decreased basic metabolic rate, malnutrition, impaired circulation, decreased sensitivity to cold temperatures and impaired neuroendocrine and autonomic system function, with diminished responses to cold including vasoconstriction, norepinephrine release, and vasomotor response.

Evidence:

  • In mentally impaired patients, the severity of hypothermia is often related to the severity of impaired judgment and the type of antipsychotic drug (19; 20; 21).
    • All classes of antipsychotic medication, including the atypical antipsychotics, have been associated with hypothermia (19; 20; 21; 22; 23; 24; 25).
    • The hypothermic effects of antipsychotic medication appear to be regulated by CNS dopamine receptors (26; 27).
  • Several studies have looked at impaired thermo-production in elderly patients requiring additional warming (28; 29; 30; 31).

Comments:

  • None.

FAQs
Albert Cheung, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Dmitri Guvakov, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Stuart Weiss, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Wenjun Zhou Martini, PhD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for continuing medical education grand rounds and lectures given.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.